PD-1 and PD-L2 expression predict relapse risk and poor survival in patients with stage III colorectal cancer

Zengin M., Zergeroglu S., Okcu O., Benek S.

CELLULAR ONCOLOGY, 2021 (SCI İndekslerine Giren Dergi) identifier identifier


Background Immune responses have long been an area of interest in cancer research. In this study, the effects of programmed cell death-1 (PD-1) and its ligand (PD-L2) on the prognosis of colorectal cancer (CRC) were investigated.